Previous studies demonstrated that activation of stromal cells in the TME can induce T cell suppression and oncogenic signaling pathway activation via complex cellular and biological reconfiguration mechanisms (36, 37), attenuating the tumor response to PD-L1 blockade (28). Here, CD274 is linked to neoplasm.